Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-Mediated transport of HDL

Cell Metabolism

Volumn 17, Issue 5, 2013, Pages 671-684

  Lim, Hwee Ying ^a   Thiam, Chung Hwee ^a   Yeo, Kim Pin ^a   Bisoendial, Radjesh ^b   Hii, Chung Shii ^a   McGrath, Kristine C Y ^c   Tan, Kar Wai ^a,d   Heather, Alison ^c   Alexander, J Steven Jonathan ^e   Angeli, Veronique ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b CENTENARY INSTITUTE   (Australia)

^c UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^d AGENCY FOR SCIENCE   (Singapore)

^e LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NEUTRALIZING ANTIBODY; SCAVENGER RECEPTOR BI;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CIRCULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; LYMPHATIC DRAINAGE; MOUSE; NONHUMAN; PASSIVE TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE CHOLESTEROL TRANSPORT; RNA INTERFERENCE; TRANSCYTOSIS; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; BIOLOGICAL TRANSPORT; CHOLESTEROL; ENDOTHELIAL CELLS; ENDOTHELIUM; HUMANS; LIPOPROTEINS, HDL; LYMPHATIC VESSELS; MICE; SCAVENGER RECEPTORS, CLASS B; TRANSCYTOSIS;

EID: 84877264563     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2013.04.002     Document Type: Article

References (53)

1. T. Ando, P. Jordan, T. Joh, Y. Wang, M.H. Jennings, J. Houghton, and J.S. Alexander Isolation and characterization of a novel mouse lymphatic endothelial cell line: SV-LEC Lymphat. Res. Biol. 3 2005 105 115
2. V. Angeli, J. Llodrá, J.X. Rong, K. Satoh, S. Ishii, T. Shimizu, E.A. Fisher, and G.J. Randolph Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization Immunity 21 2004 561 574
3. M.L. Armstrong, S.N. Mathur, G.N. Sando, and M.B. Megan Lipid metabolism in xanthomatous skin of hypercholesterolemic rabbits Am. J. Pathol. 125 1986 339 348
4. P. Baluk, J. Fuxe, H. Hashizume, T. Romano, E. Lashnits, S. Butz, D. Vestweber, M. Corada, C. Molendini, E. Dejana, and D.M. McDonald Functionally specialized junctions between endothelial cells of lymphatic vessels J. Exp. Med. 204 2007 2349 2362
5. B.W. Berger, I. Kantor, and H.S. Maier Xanthomatosis and lymphedema Arch. Dermatol. 105 1972 730 731 passim
6. J.W. Breslin, N. Gaudreault, K.D. Watson, R. Reynoso, S.Y. Yuan, and M.H. Wu Vascular endothelial growth factor-C stimulates the lymphatic pump by a VEGF receptor-3-dependent mechanism Am. J. Physiol. Heart Circ. Physiol. 293 2007 H709 H718
7. C.J. Cooke, M.N. Nanjee, I.P. Stepanova, W.L. Olszewski, and N.E. Miller Variations in lipid and apolipoprotein concentrations in human leg lymph: effects of posture and physical exercise Atherosclerosis 173 2004 39 45
8. C. Danussi, P. Spessotto, A. Petrucco, B. Wassermann, P. Sabatelli, M. Montesi, R. Doliana, G.M. Bressan, and A. Colombatti Emilin1 deficiency causes structural and functional defects of lymphatic vasculature Mol. Cell. Biol. 28 2008 4026 4039
9. H.R. Davis Jr., D.S. Compton, L. Hoos, and G. Tetzloff Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice Arterioscler. Thromb. Vasc. Biol. 21 2001 2032 2038
10. J.B. Dixon Lymphatic lipid transport: sewer or subway? Trends Endocrinol. Metab. 21 2010 480 487
11. D. Feng, J.A. Nagy, H.F. Dvorak, and A.M. Dvorak Ultrastructural studies define soluble macromolecular, particulate, and cellular transendothelial cell pathways in venules, lymphatic vessels, and tumor-associated microvessels in man and animals Microsc. Res. Tech. 57 2002 289 326
12. R.M. Frankel, and R. Capone Xanthelasmas and xanthomas- cutaneous clues to systemic lipid disorders Clin. Eye Vis. Care 7 1995 117 128
13. A.C. Goldberg, P.N. Hopkins, P.P. Toth, C.M. Ballantyne, D.J. Rader, J.G. Robinson, S.R. Daniels, S.S. Gidding, S.D. de Ferranti, and M.K. Ito Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia J. Clin. Lipidol. 5 2011 133 140
14. A. Horra, J. Salazar, R. Ferré, J.C. Vallvé, M. Guardiola, R. Rosales, L. Masana, and J. Ribalta Prox-1 and FOXC2 gene expression in adipose tissue: A potential contributory role of the lymphatic system to familial combined hyperlipidaemia Atherosclerosis 206 2009 343 345
15. J.A. Hunter, W.N. Morley, and G.A. Peterkin Xanthomatosis secondary to lymphoedema Trans. St Johns Hosp. Dermatol. Soc. 56 1970 143 148
16. F. Ikomi, Y. Kawai, J. Nakayama, N. Ogiwara, K. Sasaki, R. Mizuno, and T. Ohhashi Critical roles of VEGF-C-VEGF receptor 3 in reconnection of the collecting lymph vessels in mice Microcirculation 15 2008 591 603
17. S. Ishibashi, J.L. Goldstein, M.S. Brown, J. Herz, and D.K. Burns Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice J. Clin. Invest. 93 1994 1885 1893
18. L.A. Johnson, and D.G. Jackson Inflammation-induced secretion of CCL21 in lymphatic endothelium is a key regulator of integrin-mediated dendritic cell transmigration Int. Immunol. 22 2010 839 849
19. P.J. Kuhlencordt, P. Padmapriya, S. Rützel, J. Schödel, K. Hu, A. Schäfer, P.L. Huang, G. Ertl, and J. Bauersachs Ezetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko mice Atherosclerosis 202 2009 48 57
20. E.D. Labonté, P.N. Howles, N.A. Granholm, J.C. Rojas, J.P. Davies, Y.A. Ioannou, and D.Y. Hui Class B type I scavenger receptor is responsible for the high affinity cholesterol binding activity of intestinal brush border membrane vesicles Biochim. Biophys. Acta 1771 2007 1132 1139
21. M. Lamant, F. Smih, R. Harmancey, P. Philip-Couderc, A. Pathak, J. Roncalli, M. Galinier, X. Collet, P. Massabuau, J.M. Senard, and P. Rouet ApoO, a novel apolipoprotein, is an original glycoprotein up-regulated by diabetes in human heart J. Biol. Chem. 281 2006 36289 36302
22. L.V. Leak The structure of lymphatic capillaries in lymph formation Fed. Proc. 35 1976 1863 1871
23. H.Y. Lim, J.M. Rutkowski, J. Helft, S.T. Reddy, M.A. Swartz, G.J. Randolph, and V. Angeli Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration Am. J. Pathol. 175 2009 1328 1337
24. I. Lorenzi, A. von Eckardstein, C. Cavelier, S. Radosavljevic, and L. Rohrer Apolipoprotein A-I but not high-density lipoproteins are internalised by RAW macrophages: roles of ATP-binding cassette transporter A1 and scavenger receptor BI J. Mol. Med. 86 2008 171 183
25. M. Muthuchamy, and D. Zawieja Molecular regulation of lymphatic contractility Ann. N Y Acad. Sci. 1131 2008 89 99
26. M.N. Nanjee, C.J. Cooke, J.S. Wong, R.L. Hamilton, W.L. Olszewski, and N.E. Miller Composition and ultrastructure of size subclasses of normal human peripheral lymph lipoproteins: quantification of cholesterol uptake by HDL in tissue fluids J. Lipid Res. 42 2001 639 648
27. T.V. Petrova, T. Karpanen, C. Norrmén, R. Mellor, T. Tamakoshi, D. Finegold, R. Ferrell, D. Kerjaschki, P. Mortimer, and S. Ylä-Herttuala Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis Nat. Med. 10 2004 974 981
28. H. Pflicke, and M. Sixt Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels J. Exp. Med. 206 2009 2925 2935
29. S. Podgrabinska, P. Braun, P. Velasco, B. Kloos, M.S. Pepper, and M. Skobe Molecular characterization of lymphatic endothelial cells Proc. Natl. Acad. Sci. USA 99 2002 16069 16074
30. M.K. Polano Cutaneous xanthomatosis in relation to the blood lipoprotein pattern Br. J. Dermatol. 81 Suppl 2 1969 2 39-48
31. D.J. Rader, E.T. Alexander, G.L. Weibel, J. Billheimer, and G.H. Rothblat The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis J. Lipid Res. 50 Suppl 2009 S189 S194
32. D. Reichl Lipoproteins of human peripheral lymph Eur. Heart J. 11 Suppl E 1990 230 236
33. D. Reichl Extravascular circulation of lipoproteins: their role in reverse transport of cholesterol Atherosclerosis 105 1994 117 129
34. D. Reichl, and N.E. Miller Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism Arteriosclerosis 9 1989 785 797
35. D. Reichl, L.A. Simons, N.B. Myant, J.J. Pflug, and G.L. Mills The lipids and lipoproteins of human peripheral lymph, with observations on the transport of cholesterol from plasma and tissues into lymph Clin. Sci. Mol. Med. 45 1973 313 329
36. A. Rigotti, B.L. Trigatti, M. Penman, H. Rayburn, J. Herz, and M. Krieger A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism Proc. Natl. Acad. Sci. USA 94 1997 12610 12615
37. P.S. Roheim, L. Dory, M. Lefevre, and C.H. Sloop Lipoproteins in interstitial fluid of dogs: implications for a role in reverse cholesterol transport Eur. Heart J. 11 Suppl E 1990 225 229
38. L. Rohrer, P.M. Ohnsorg, M. Lehner, F. Landolt, F. Rinninger, and A. von Eckardstein High-density lipoprotein transport through aortic endothelial cells involves scavenger receptor BI and ATP-binding cassette transporter G1 Circ. Res. 104 2009 1142 1150
39. J.M. Rutkowski, M. Moya, J. Johannes, J. Goldman, and M.A. Swartz Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9 Microvasc. Res. 72 2006 161 171
40. A. Schirger, E.G. Harrison Jr., and J.M. Janes Idiopathic lymphedema. Review of 131 cases JAMA 182 1962 14 22
41. G.W. Schmid-Schönbein Microlymphatics and lymph flow Physiol. Rev. 70 1990 987 1028
42. S. Schulte-Merker, A. Sabine, and T.V. Petrova Lymphatic vascular morphogenesis in development, physiology, and disease J. Cell Biol. 193 2011 607 618
43. K. Schumann, T. Lämmermann, M. Bruckner, D.F. Legler, J. Polleux, J.P. Spatz, G. Schuler, R. Förster, M.B. Lutz, L. Sorokin, and M. Sixt Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells Immunity 32 2010 703 713
44. C.H. Sloop, L. Dory, and P.S. Roheim Interstitial fluid lipoproteins J. Lipid Res. 28 1987 225 237
45. C.P. Sparrow, S. Patel, J. Baffic, Y.S. Chao, M. Hernandez, M.H. Lam, J. Montenegro, S.D. Wright, and P.A. Detmers A fluorescent cholesterol analog traces cholesterol absorption in hamsters and is esterified in vivo and in vitro J. Lipid Res. 40 1999 1747 1757
46. A. Szuba, M. Skobe, M.J. Karkkainen, W.S. Shin, D.P. Beynet, N.B. Rockson, N. Dakhil, S. Spilman, M.L. Goris, and H.W. Strauss Therapeutic lymphangiogenesis with human recombinant VEGF-C FASEB J. 16 2002 1985 1987
47. O. Tal, H.Y. Lim, I. Gurevich, I. Milo, Z. Shipony, L.G. Ng, V. Angeli, and G. Shakhar DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling J. Exp. Med. 208 2011 2141 2153
48. A.R. Tall Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins J. Intern. Med. 263 2008 256 273
49. T. Tammela, and K. Alitalo Lymphangiogenesis: Molecular mechanisms and future promise Cell 140 2010 460 476
50. J.H. van Ree, M.J. Gijbels, W.J. van den Broek, M.H. Hofker, and L.M. Havekes Atypical xanthomatosis in apolipoprotein E-deficient mice after cholesterol feeding Atherosclerosis 112 1995 237 243
51. X. Wang, H.L. Collins, M. Ranalletta, I.V. Fuki, J.T. Billheimer, G.H. Rothblat, A.R. Tall, and D.J. Rader Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo J. Clin. Invest. 117 2007 2216 2224
52. Y. Zhang, I. Zanotti, M.P. Reilly, J.M. Glick, G.H. Rothblat, and D.J. Rader Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo Circulation 108 2003 661 663
53. Y. Zhang, J.R. Da Silva, M. Reilly, J.T. Billheimer, G.H. Rothblat, and D.J. Rader Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo J. Clin. Invest. 115 2005 2870 2874